These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 866224

  • 21. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM, Mielke D, Bishop G, Oelsner T, Guerrero-Figueroa R.
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Transition to Community: a program to help clients with schizophrenia move from inpatient to community care; a pilot study.
    Price LM.
    Arch Psychiatr Nurs; 2007 Dec; 21(6):336-44. PubMed ID: 18037444
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Conceptual measurement as a mean of assessing therapeutic changes in schizophrenia.
    Askar AM, Rakhawy YT, Shaalan M.
    J Egypt Med Assoc; 1968 Dec; 51(1):1-17. PubMed ID: 4386414
    [No Abstract] [Full Text] [Related]

  • 28. [Effects of TPN-12 Sandoz in schizophrenia].
    Pogorzelski W, Rogiewicz A, Wojdyslawska I.
    Psychiatr Pol; 1973 Dec; 7(1):65-8. PubMed ID: 4715834
    [No Abstract] [Full Text] [Related]

  • 29. Factors important for compliance among Croatian patients suffering from schizophrenia--how to improve psychiatric services in Croatia?
    Martić-Biocina S, Barić V.
    Psychiatr Danub; 2005 Jun; 17(1-2):36-41. PubMed ID: 16395842
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of the efficacy of psychoeducative groups in schizophrenic patients].
    Eguiluz I, González Torres MA, Muñoz P, Guadilla M, González G.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Jun; 26(1):29-34. PubMed ID: 9580354
    [Abstract] [Full Text] [Related]

  • 34. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics.
    Klerman GL, Goldberg SG, Davis D.
    Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Noncompliance in schizophrenia.
    Babiker IE.
    Psychiatr Dev; 1986 Nov; 4(4):329-37. PubMed ID: 2883650
    [Abstract] [Full Text] [Related]

  • 39. Piperacetazine in chronic schizophrenia.
    Climo HJ, Billett B.
    JFMA; 1972 Mar; 59(3):33-6. PubMed ID: 5030683
    [No Abstract] [Full Text] [Related]

  • 40. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM.
    Psychiatry Res; 2008 Nov 30; 161(2):235-47. PubMed ID: 18849080
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.